Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
TS Corporation, formerly known as Taihan Sugar, is a prominent South Korean conglomerate that has significantly expanded its operations into the life sciences and biotechnology sectors. The company's Bio Business division is a global leader in the development and mass production of functional food ingredients, most notably low-calorie sweeteners such as allulose and tagatose, which are used to manage metabolic health. Additionally, TS Corporation is active in the probiotics market and the animal health sector, producing specialized feed additives and nutritional supplements through advanced fermentation technology. Operating a dedicated Bio Research Center, the company focuses on metabolic engineering and bio-material innovation to provide health-oriented solutions for both human and animal nutrition. TS Corporation is publicly traded on the Korea Exchange and maintains a significant presence in the global functional ingredient and wellness industries.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on T.S. Corporation.